Dyne Therapeutics’ $374.3 Million Common Stock Offering

Wilmer Cutler Pickering Hale and Dorr advised Dyne Therapeutics, Inc. on the offering, and Cooley advised the underwriters.Dyne Therapeutics, Inc. (Nasdaq:DYN) announced the closing of its…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now